AnnotSV_ID	SV_chrom	SV_start	SV_end	SV_length	SV_type	Samples_ID	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	HG002	Annotation_mode	Gene_name	Gene_count	Tx	Tx_start	Tx_end	Overlapped_tx_length	Overlapped_CDS_length	Overlapped_CDS_percent	Frameshift	Exon_count	Location	Location2	Dist_nearest_SS	Nearest_SS_type	Intersect_start	Intersect_end	RE_gene	P_gain_phen	P_gain_hpo	P_gain_source	P_gain_coord	P_loss_phen	P_loss_hpo	P_loss_source	P_loss_coord	P_ins_phen	P_ins_hpo	P_ins_source	P_ins_coord	P_snvindel_nb	P_snvindel_phen	B_gain_source	B_gain_coord	B_loss_source	B_loss_coord	B_ins_source	B_ins_coord	B_inv_source	B_inv_coord	TAD_coordinate	ENCODE_experiment	GC_content_left	GC_content_right	Repeat_coord_left	Repeat_type_left	Repeat_coord_right	Repeat_type_right	Gap_left	Gap_right	SegDup_left	SegDup_right	ENCODE_blacklist_left	ENCODE_blacklist_characteristics_left	ENCODE_blacklist_right	ENCODE_blacklist_characteristics_right	ACMG	HI	TS	DDD_HI_percent	DDD_status	DDD_mode	DDD_consequence	DDD_disease	DDD_pmid	ExAC_delZ	ExAC_dupZ	ExAC_cnvZ	ExAC_synZ	ExAC_misZ	OMIM_ID	OMIM_phenotype	OMIM_inheritance	OMIM_morbid	OMIM_morbid_candidate	LOEUF_bin	GnomAD_pLI	ExAC_pLI	AnnotSV_ranking_score	AnnotSV_ranking_criteria	ACMG_class
1_149390802_149390841_<STR20>_1	1	149390802	149390841		<STR20>	HG002	.	A	<STR20>	.	PASS	END=149390841;REF=13;RL=39;RU=GGC;VARID=NOTCH2NL;REPID=NOTCH2NL	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/1:SPANNING/SPANNING:20/20:20-20/20-20:11/11:19/19:0/0:28.338021	full	NOTCH2NLC	1																																				IMH	1:10187872-186857210;1:16798093-234784887;1:68663391-188869781;1:75962659-179353269;1:107555342-232824950			0.730	0.745	1:149390802-149390842	(GGC)n	1:149390802-149390842	(GGC)n			1:149366550-149471561;1:149366550-149480964;1:149366550-149480964;1:149372304-149480964	1:149366550-149471561;1:149366550-149480964;1:149366550-149480964;1:149372304-149480964																			618025			yes							NA
1_149390802_149390841_<STR20>_1	1	149390802	149390841		<STR20>	HG002	.	A	<STR20>	.	PASS	END=149390841;REF=13;RL=39;RU=GGC;VARID=NOTCH2NL;REPID=NOTCH2NL	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/1:SPANNING/SPANNING:20/20:20-20/20-20:11/11:19/19:0/0:28.338021	split	NOTCH2NLC		NM_001364013	149390637	149465302	39	39	4	no	5	exon1-exon1	CDS	81	5'	149390802	149390841																						IMH	1:10187872-186857210;1:16798093-234784887;1:68663391-188869781;1:75962659-179353269;1:107555342-232824950																															618025	Neuronal intranuclear inclusion disease, 603472 (3);Tremor, hereditary essential, 6, 618866 (3)	AD	yes							full=NA
12_6936716_6936773_<STR17>_1	12	6936716	6936773		<STR17>	HG002	.	C	<STR17>	.	PASS	END=6936773;REF=19;RL=57;RU=CAG;VARID=ATN1;REPID=ATN1	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:19/17:19-19/17-17:15/18:42/42:0/0:44.344511	full	ATN1	1																																				IMH	12:3226062-8351658			0.625	0.635	12:6936716-6936775	(CAG)n	12:6936716-6936775	(CAG)n												8.41						-0.134672929864199	0.401252225475924	0.275342475051114	1.78647174185779	2.87005246024806	607462			yes			9.9992e-01	9.9853e-01			NA
12_6936716_6936773_<STR17>_1	12	6936716	6936773		<STR17>	HG002	.	C	<STR17>	.	PASS	END=6936773;REF=19;RL=57;RU=CAG;VARID=ATN1;REPID=ATN1	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:19/17:19-19/17-17:15/18:42/42:0/0:44.344511	split	ATN1		NM_001007026	6924458	6942321	57	57	1	no	10	exon5-exon5	CDS	788	5'	6936716	6936773																						IMH	12:3226062-8351658																				8.41	probable	monoallelic	all missense/in frame	congenital hypotonia, epilepsy, developmental delay, digit abnormalities	30827498	-0.134672929864199	0.401252225475924	0.275342475051114	1.78647174185779	2.87005246024806	607462	Congenital hypotonia, epilepsy, developmental delay, and digital anomalies, 618494 (3);Dentatorubral-pallidoluysian atrophy, 125370 (3)	AD	yes		0	9.9992e-01	9.9853e-01			full=NA
12_50505001_50505022_<STR17>_1	12	50505001	50505022		<STR17>	HG002	.	T	<STR17>	.	PASS	END=50505022;REF=7;RL=21;RU=GGC;VARID=DIP2B;REPID=DIP2B	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:7/17:7-7/17-17:20/15:21/32:0/0:44.099513	full	DIP2B	1																																				IMH	12:30757997-51226316;12:40539484-113039119			0.735	0.740	12:50505001-50505053	(GGC)n	12:50505001-50505053	(GGC)n												27.8						1.49877452958391	1.74259227422189	1.85937346161046	-0.342715073991275	2.94498922134151	611379			yes			9.9924e-01	9.9967e-01			NA
12_50505001_50505022_<STR17>_1	12	50505001	50505022		<STR17>	HG002	.	T	<STR17>	.	PASS	END=50505022;REF=7;RL=21;RU=GGC;VARID=DIP2B;REPID=DIP2B	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:7/17:7-7/17-17:20/15:21/32:0/0:44.099513	split	DIP2B		NM_173602	50504984	50748657	21	0	0	no	38	exon1-exon1	5'UTR	218	5'	50505001	50505022																						IMH	12:30757997-51226316;12:40539484-113039119																				27.8	possible	monoallelic	cis-regulatory or promotor mutation	MENTAL RETARDATION, FRA12A TYPE	17236128	1.49877452958391	1.74259227422189	1.85937346161046	-0.342715073991275	2.94498922134151	611379	Mental retardation, FRA12A type, 136630 (3)	AD	yes		0	9.9924e-01	9.9967e-01			full=NA
12_111598949_111599018_<STR22>,<STR30>_1	12	111598949	111599018		<STR22>,<STR30>	HG002	.	G	<STR22>,<STR30>	.	PASS	END=111599018;REF=23;RL=69;RU=GCT;VARID=ATXN2;REPID=ATXN2	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:22/30:22-22/30-30:17/5:51/61:0/0:43.772850	full	ATXN2	1															ATXN2-AS																					IMH	12:40539484-113039119			0.710	0.730	12:111598827-111598874;12:111598949-111599019	(CGAGGA)n;(GCT)n	12:111598949-111599019	(GCT)n												4.16						1.20996384516475	1.41321926854445	1.65682542305082	1.0016219221687	2.01107946752925	601517			yes	yes		8.5289e-01	9.9986e-01			NA
12_111598949_111599018_<STR22>,<STR30>_1	12	111598949	111599018		<STR22>,<STR30>	HG002	.	G	<STR22>,<STR30>	.	PASS	END=111599018;REF=23;RL=69;RU=GCT;VARID=ATXN2;REPID=ATXN2	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:22/30:22-22/30-30:17/5:51/61:0/0:43.772850	split	ATXN2		NM_001372574	111452213	111599315	69	69	1	no	25	exon1-exon1	CDS	166	5'	111598949	111599018																						IMH	12:40539484-113039119																				4.16						1.20996384516475	1.41321926854445	1.65682542305082	1.0016219221687	2.01107946752925	601517	Spinocerebellar ataxia 2, 183090 (3);(Amyotrophic lateral sclerosis, susceptibility to, 13), 183090 (3);(Parkinson disease, late-onset, susceptibility to), 168600 (3)	AD;Multifactorial, AD	yes	yes	1	8.5289e-01	9.9986e-01			full=NA
13_70139353_70139383_<STR8>,<STR11>_1	13	70139353	70139383		<STR8>,<STR11>	HG002	.	A	<STR8>,<STR11>	.	PASS	END=70139383;REF=10;RL=30;RU=CTA;VARID=ATXN8OS_CTA;REPID=ATXN8OS_CTA	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:8/11:8-8/11-11:18/15:13/14:0/0:32.257977	full	ATXN8OS	1																																				IMH	13:32383136-100111306;13:42622758-110043479;13:69697530-72987495			0.455	0.400	13:70139351-70139383;13:70139383-70139429	(TAC)n;(CTG)n	13:70139351-70139383;13:70139383-70139429	(TAC)n;(CTG)n																							603680			yes	yes						NA
13_70139353_70139383_<STR8>,<STR11>_1	13	70139353	70139383		<STR8>,<STR11>	HG002	.	A	<STR8>,<STR11>	.	PASS	END=70139383;REF=10;RL=30;RU=CTA;VARID=ATXN8OS_CTA;REPID=ATXN8OS_CTA	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:8/11:8-8/11-11:18/15:13/14:0/0:32.257977	split	ATXN8OS		NR_002717	70107212	70139753	30	0	0	no	5	exon5-exon5	UTR	113	3'	70139353	70139383																						IMH	13:32383136-100111306;13:42622758-110043479;13:69697530-72987495																															603680	Spinocerebellar ataxia 8, 608768 (3);(Parkinson disease, susceptibility to), 168600 (3)	AD;Multifactorial, AD	yes	yes						full=NA
13_70139383_70139428_<STR16>_1	13	70139383	70139428		<STR16>	HG002	.	A	<STR16>	.	PASS	END=70139428;REF=15;RL=45;RU=CTG;VARID=ATXN8OS;REPID=ATXN8OS	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:15/16:15-15/16-16:12/15:29/29:0/0:32.257977	full	ATXN8OS	1																																				IMH	13:32383136-100111306;13:42622758-110043479;13:69697530-72987495			0.400	0.345	13:70139351-70139383;13:70139383-70139429	(TAC)n;(CTG)n	13:70139351-70139383;13:70139383-70139429	(TAC)n;(CTG)n																							603680			yes	yes						NA
13_70139383_70139428_<STR16>_1	13	70139383	70139428		<STR16>	HG002	.	A	<STR16>	.	PASS	END=70139428;REF=15;RL=45;RU=CTG;VARID=ATXN8OS;REPID=ATXN8OS	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:15/16:15-15/16-16:12/15:29/29:0/0:32.257977	split	ATXN8OS		NR_002717	70107212	70139753	45	0	0	no	5	exon5-exon5	UTR	143	3'	70139383	70139428																						IMH	13:32383136-100111306;13:42622758-110043479;13:69697530-72987495																															603680	Spinocerebellar ataxia 8, 608768 (3);(Parkinson disease, susceptibility to), 168600 (3)	AD;Multifactorial, AD	yes	yes						full=NA
14_92071009_92071042_<STR20>,<STR24>_1	14	92071009	92071042		<STR20>,<STR24>	HG002	.	C	<STR20>,<STR24>	.	PASS	END=92071042;REF=11;RL=33;RU=GCT;VARID=ATXN3;REPID=ATXN3	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:20/24:20-20/24-24:16/5:25/27:0/0:36.749594	full	ATXN3	1																																				IMH	14:23629192-97505158			0.445	0.415	14:92071010-92071052	(CTG)n	14:92071010-92071052	(CTG)n												9.03						1.0835899357099	-0.225677633839447	0.2560504644898	0.309150553063112	0.806176274028153	607047			yes			1.0575e-01	1.7636e-01			NA
14_92071009_92071042_<STR20>,<STR24>_1	14	92071009	92071042		<STR20>,<STR24>	HG002	.	C	<STR20>,<STR24>	.	PASS	END=92071042;REF=11;RL=33;RU=GCT;VARID=ATXN3;REPID=ATXN3	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:20/24:20-20/24-24:16/5:25/27:0/0:36.749594	split	ATXN3		NM_001127696	92058551	92106582	33	33	3	no	10	exon9-exon9	CDS	11	3'	92071009	92071042																						IMH	14:23629192-97505158																				9.03						1.0835899357099	-0.225677633839447	0.2560504644898	0.309150553063112	0.806176274028153	607047	Machado-Joseph disease, 109150 (3)	AD	yes		2	1.0575e-01	1.7636e-01			full=NA
16_87604287_87604329_<STR16>_1	16	87604287	87604329		<STR16>	HG002	.	C	<STR16>	.	PASS	END=87604329;REF=14;RL=42;RU=CTG;VARID=JPH3;REPID=JPH3	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/1:SPANNING/SPANNING:16/16:16-16/16-16:29/29:35/35:0/0:43.854516	full	JPH3	1																																				IMH	16:29226963-88193867			0.605	0.630	16:87604282-87604329	(GCT)n	16:87604282-87604329	(GCT)n												33.27						0.216965522472953	-1.0762112530597	-0.765482067324543	-0.289523673349551	1.27589782238618	605268			yes			9.9855e-01	9.8618e-01			NA
16_87604287_87604329_<STR16>_1	16	87604287	87604329		<STR16>	HG002	.	C	<STR16>	.	PASS	END=87604329;REF=14;RL=42;RU=CTG;VARID=JPH3;REPID=JPH3	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/1:SPANNING/SPANNING:16/16:16-16/16-16:29/29:35/35:0/0:43.854516	split	JPH3		NM_001271604	87602507	87604648	42	42	7	no	2	exon2-exon2	CDS	48	3'	87604287	87604329																						IMH	16:29226963-88193867																				33.27						0.216965522472953	-1.0762112530597	-0.765482067324543	-0.289523673349551	1.27589782238618	605268	Huntington disease-like 2, 606438 (3)	AD	yes		0	9.9855e-01	9.8618e-01			full=NA
18_55586155_55586227_<STR14>,<STR32>_1	18	55586155	55586227		<STR14>,<STR32>	HG002	.	G	<STR14>,<STR32>	.	PASS	END=55586227;REF=24;RL=72;RU=CAG;VARID=TCF4;REPID=TCF4	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:14/32:14-14/32-32:12/5:20/27:0/0:33.074635	full	TCF4	1															TCF4 (morbid)																									0.585	0.515	18:55586113-55586153;18:55586153-55586229	(GAG)n;(AGC)n	18:55586113-55586153;18:55586153-55586229	(GAG)n;(AGC)n										3		0.38						1.47734795336459	0.574828836787397	1.03093023316889	0.115006056248647	4.45337179274477	602228;602272			yes	yes		9.9981e-01	9.9987e-01			NA
18_55586155_55586227_<STR14>,<STR32>_1	18	55586155	55586227		<STR14>,<STR32>	HG002	.	G	<STR14>,<STR32>	.	PASS	END=55586227;REF=24;RL=72;RU=CAG;VARID=TCF4;REPID=TCF4	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:14/32:14-14/32-32:12/5:20/27:0/0:33.074635	split	TCF4		NM_001083962	55222184	55588192	72	0	0	no	20	intron2-intron2	CDS	803	3'	55586155	55586227																																									3	0	0.38	confirmed	monoallelic	loss of function	PITT-HOPKINS SYNDROME	22670824;20184619;29695756;27132474;18728071;19235238;17436255;23528641;22045651;19938247;30848346;29604340;20205897;17436254	1.47734795336459	0.574828836787397	1.03093023316889	0.115006056248647	4.45337179274477	602228;602272	Corneal dystrophy, Fuchs endothelial, 3, 613267 (3);Pitt-Hopkins syndrome, 610954 (3);(Diabetes mellitus, type 2, susceptibility to), 125853 (3)	AD;AD	yes	yes	0	9.9981e-01	9.9987e-01			full=NA
19_13207858_13207897_<STR11>_1	19	13207858	13207897		<STR11>	HG002	.	C	<STR11>	.	PASS	END=13207897;REF=13;RL=39;RU=CTG;VARID=CACNA1A;REPID=CACNA1A	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/1:SPANNING/SPANNING:11/11:11-11/11-11:44/44:18/18:0/0:40.342888	full	CACNA1A	1																																				IMH	19:1692675-41507766;19:12342310-19691845			0.770	0.775	19:13207858-13207898	(CTG)n	19:13207858-13207898	(CTG)n										3		35.52						1.41338495639277	1.65083645536139	1.86751979318996	1.18148330722263	7.24830614237983	601011			yes							NA
19_13207858_13207897_<STR11>_1	19	13207858	13207897		<STR11>	HG002	.	C	<STR11>	.	PASS	END=13207897;REF=13;RL=39;RU=CTG;VARID=CACNA1A;REPID=CACNA1A	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/1:SPANNING/SPANNING:11/11:11-11/11-11:44/44:18/18:0/0:40.342888	split	CACNA1A		NM_001127222	13206442	13506479	39	39	0	no	47	exon47-exon47	CDS	156	3'	13207858	13207897																						IMH	19:1692675-41507766;19:12342310-19691845																		3	0	35.52	probable	monoallelic	all missense/in frame	EPILEPTIC ENCEPHALOPATHY	28927557;28742085;29366381;27476654;23934111	1.41338495639277	1.65083645536139	1.86751979318996	1.18148330722263	7.24830614237983	601011	Developemental and epileptic encephalopahty 42, 617106 (3);Episodic ataxia, type 2, 108500 (3);Migraine, familial hemiplegic, 1, 141500 (3);Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 (3);Spinocerebellar ataxia 6, 183086 (3)	AD	yes		0	1.0000e+00	1.0000e+00			full=NA
19_45770204_45770264_<STR11>_1	19	45770204	45770264		<STR11>	HG002	.	C	<STR11>	.	PASS	END=45770264;REF=20;RL=60;RU=CAG;VARID=DMPK;REPID=DMPK	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/1:SPANNING/SPANNING:11/11:11-11/11-11:41/41:22/22:0/0:50.796106	full	DM1-AS;DMPK	2																												6	Steinert_myotonic_dystrophy_syndrome											0.650	0.690	19:45770204-45770266;19:45770290-45770333	(CAG)n;(GCCCCG)n	19:45770204-45770266;19:45770290-45770333	(CAG)n;(GCCCCG)n												49.83						0.129585563803887	1.01867790101199	0.821144234301687	0.425893209308494	1.39938895128029	605377			yes			3.8339e-02	3.3081e-02			NA
19_45770204_45770264_<STR11>_1	19	45770204	45770264		<STR11>	HG002	.	C	<STR11>	.	PASS	END=45770264;REF=20;RL=60;RU=CAG;VARID=DMPK;REPID=DMPK	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/1:SPANNING/SPANNING:11/11:11-11/11-11:41/41:22/22:0/0:50.796106	split	DM1-AS		NR_147193	45767795	45771883	60	0	0	no	2	intron1-intron1	UTR	1225	3'	45770204	45770264														6	Steinert_myotonic_dystrophy_syndrome																																																	full=NA
19_45770204_45770264_<STR11>_1	19	45770204	45770264		<STR11>	HG002	.	C	<STR11>	.	PASS	END=45770264;REF=20;RL=60;RU=CAG;VARID=DMPK;REPID=DMPK	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/1:SPANNING/SPANNING:11/11:11-11/11-11:41/41:22/22:0/0:50.796106	split	DMPK		NM_001288765	45769708	45779619	60	0	0	no	13	exon13-exon13	3'UTR	376	3'	45770204	45770264														6	Steinert_myotonic_dystrophy_syndrome																												49.83	confirmed	monoallelic	dominant negative	DYSTROPHIA MYOTONICA TYPE 1		0.129585563803887	1.01867790101199	0.821144234301687	0.425893209308494	1.39938895128029	605377	Myotonic dystrophy 1, 160900 (3)	AD	yes		2	3.8339e-02	3.3081e-02			full=NA
2_190880872_190880920_<STR8>,<STR14>_1	2	190880872	190880920		<STR8>,<STR14>	HG002	.	C	<STR8>,<STR14>	.	PASS	END=190880920;REF=16;RL=48;RU=GCA;VARID=GLS;REPID=GLS	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:8/14:8-8/14-14:18/36:18/27:0/0:48.182802	full	GLS	1																																				IMH	2:65359566-213949290;2:121478682-234514775;2:136890293-221566955;2:163662940-202335758			0.670	0.660	2:190880872-190880920	(GCA)n	2:190880872-190880920	(GCA)n												10.46						-1.28770507127557	-0.198977549193212	-0.605804540583427	0.351658988991989	3.42972030709504	138280			yes	yes		9.6154e-01	9.9930e-01			NA
2_190880872_190880920_<STR8>,<STR14>_1	2	190880872	190880920		<STR8>,<STR14>	HG002	.	C	<STR8>,<STR14>	.	PASS	END=190880920;REF=16;RL=48;RU=GCA;VARID=GLS;REPID=GLS	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:8/14:8-8/14-14:18/36:18/27:0/0:48.182802	split	GLS		NM_001256310	190880820	190935289	48	0	0	no	15	exon1-exon1	5'UTR	550	5'	190880872	190880920																						IMH	2:65359566-213949290;2:121478682-234514775;2:136890293-221566955;2:163662940-202335758																				10.46						-1.28770507127557	-0.198977549193212	-0.605804540583427	0.351658988991989	3.42972030709504	138280	?Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development, 618339 (3);Epileptic encephalopathy, early infantile, 71, 618328 (3);Global developmental delay, progressive ataxia, and elevated glutamine, 618412 (3)	AD;AR	yes	yes	1	9.6154e-01	9.9930e-01			full=NA
20_2652733_2652757_<STR7>_1	20	2652733	2652757		<STR7>	HG002	.	G	<STR7>	.	PASS	END=2652757;REF=4;RL=24;RU=GGCCTG;VARID=NOP56;REPID=NOP56	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:4/7:4-4/7-7:32/22:11/21:0/0:46.141157	full	NOP56	1															MIR1292																									0.755	0.740	20:2652732-2652775	(GGGCCT)n	20:2652732-2652775	(GGGCCT)n												12.69						0.509077577853254	0.0536939006979634	0.261155305737806	-0.284200528512332	0.733534691836002	614154			yes			6.2098e-01	9.7326e-01			NA
20_2652733_2652757_<STR7>_1	20	2652733	2652757		<STR7>	HG002	.	G	<STR7>	.	PASS	END=2652757;REF=4;RL=24;RU=GGCCTG;VARID=NOP56;REPID=NOP56	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:4/7:4-4/7-7:32/22:11/21:0/0:46.141157	split	NOP56		NM_006392	2652631	2658393	24	0	0	no	12	intron1-intron1	CDS	70	5'	2652733	2652757																																											12.69						0.509077577853254	0.0536939006979634	0.261155305737806	-0.284200528512332	0.733534691836002	614154	Spinocerebellar ataxia 36, 614153 (3)	AD	yes		1	6.2098e-01	9.7326e-01			full=NA
20_2652757_2652775_<STR2>_1	20	2652757	2652775		<STR2>	HG002	.	G	<STR2>	.	PASS	END=2652775;REF=3;RL=18;RU=CGCCTG;VARID=NOP56_CGCCTG;REPID=NOP56_CGCCTG	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/1:SPANNING/SPANNING:2/2:2-2/2-2:63/63:7/7:0/0:46.141157	full	NOP56	1															MIR1292																									0.740	0.740	20:2652732-2652775	(GGGCCT)n	20:2652732-2652775	(GGGCCT)n												12.69						0.509077577853254	0.0536939006979634	0.261155305737806	-0.284200528512332	0.733534691836002	614154			yes			6.2098e-01	9.7326e-01			NA
20_2652757_2652775_<STR2>_1	20	2652757	2652775		<STR2>	HG002	.	G	<STR2>	.	PASS	END=2652775;REF=3;RL=18;RU=CGCCTG;VARID=NOP56_CGCCTG;REPID=NOP56_CGCCTG	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/1:SPANNING/SPANNING:2/2:2-2/2-2:63/63:7/7:0/0:46.141157	split	NOP56		NM_006392	2652631	2658393	18	0	0	no	12	intron1-intron1	CDS	66	3'	2652757	2652775																																											12.69						0.509077577853254	0.0536939006979634	0.261155305737806	-0.284200528512332	0.733534691836002	614154	Spinocerebellar ataxia 36, 614153 (3)	AD	yes		1	6.2098e-01	9.7326e-01			full=NA
21_43776443_43776479_<STR2>_1	21	43776443	43776479		<STR2>	HG002	.	G	<STR2>	.	PASS	END=43776479;REF=3;RL=36;RU=CGCGGGGCGGGG;VARID=CSTB;REPID=CSTB	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/1:SPANNING/SPANNING:2/2:2-2/2-2:47/47:19/19:0/0:40.832883	full		0															CSTB (morbid)																									0.785	0.785	21:43776444-43776479	G-rich	21:43776444-43776479	G-rich																																	NA
22_45795354_45795424_<STR12>,<STR16>_1	22	45795354	45795424		<STR12>,<STR16>	HG002	.	G	<STR12>,<STR16>	.	PASS	END=45795424;REF=14;RL=70;RU=ATTCT;VARID=ATXN10;REPID=ATXN10	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:12/16:12-12/16-16:6/7:32/38:0/0:36.422931	full	ATXN10	1																																				IMH	22:44479418-47655346;22:45618166-47591502			0.265	0.380	22:45794597-45795343;22:45795354-45795424;22:45795424-45795572	L1ME1;(ATTCT)n;AluSx1	22:45794597-45795343;22:45795354-45795424;22:45795424-45795572	L1ME1;(ATTCT)n;AluSx1												78.38						0.874818832435991	1.10534962506054	1.30981496518558	0.110910978806873	-1.28470259574575	611150			yes			3.4514e-04	7.4516e-01			NA
22_45795354_45795424_<STR12>,<STR16>_1	22	45795354	45795424		<STR12>,<STR16>	HG002	.	G	<STR12>,<STR16>	.	PASS	END=45795424;REF=14;RL=70;RU=ATTCT;VARID=ATXN10;REPID=ATXN10	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:12/16:12-12/16-16:6/7:32/38:0/0:36.422931	split	ATXN10		NM_001167621	45671797	45845307	70	0	0	no	11	intron8-intron8	CDS	11534	3'	45795354	45795424																						IMH	22:44479418-47655346;22:45618166-47591502																				78.38						0.874818832435991	1.10534962506054	1.30981496518558	0.110910978806873	-1.28470259574575	611150	Spinocerebellar ataxia 10, 603516 (3)	AD	yes		3	3.4514e-04	7.4516e-01			full=NA
3_63912684_63912714_<STR12>_1	3	63912684	63912714		<STR12>	HG002	.	G	<STR12>	.	PASS	END=63912714;REF=10;RL=30;RU=GCA;VARID=ATXN7;REPID=ATXN7	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:10/12:10-10/12-12:12/10:14/14:0/0:34.707950	full	ATXN7	1																																				IMH	3:30036453-134858252			0.795	0.835	3:63912684-63912716	(GCA)n	3:63912684-63912716	(GCA)n												17.72						0.730304227093642	0.636006512326363	0.862222958307612	0.85336181383742	0.386394557252369	607640			yes			9.5950e-01	9.2856e-01			NA
3_63912684_63912714_<STR12>_1	3	63912684	63912714		<STR12>	HG002	.	G	<STR12>	.	PASS	END=63912714;REF=10;RL=30;RU=GCA;VARID=ATXN7;REPID=ATXN7	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:10/12:10-10/12-12:12/10:14/14:0/0:34.707950	split	ATXN7		NM_001377405	63863866	64003460	30	30	1	no	13	exon3-exon3	CDS	97	3'	63912684	63912714																						IMH	3:30036453-134858252																				17.72						0.730304227093642	0.636006512326363	0.862222958307612	0.85336181383742	0.386394557252369	607640	Spinocerebellar ataxia 7, 164500 (3)	AD	yes		1	9.5950e-01	9.2856e-01			full=NA
3_63912714_63912726_<STR5>_1	3	63912714	63912726		<STR5>	HG002	.	A	<STR5>	.	PASS	END=63912726;REF=4;RL=12;RU=GCC;VARID=ATXN7_GCC;REPID=ATXN7_GCC	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:4/5:4-4/5-5:16/10:9/10:0/0:34.707950	full	ATXN7	1																																				IMH	3:30036453-134858252			0.835	0.845	3:63912684-63912716	(GCA)n	3:63912684-63912716	(GCA)n												17.72						0.730304227093642	0.636006512326363	0.862222958307612	0.85336181383742	0.386394557252369	607640			yes			9.5950e-01	9.2856e-01			NA
3_63912714_63912726_<STR5>_1	3	63912714	63912726		<STR5>	HG002	.	A	<STR5>	.	PASS	END=63912726;REF=4;RL=12;RU=GCC;VARID=ATXN7_GCC;REPID=ATXN7_GCC	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:4/5:4-4/5-5:16/10:9/10:0/0:34.707950	split	ATXN7		NM_001377405	63863866	64003460	12	12	0	no	13	exon3-exon3	CDS	127	3'	63912714	63912726																						IMH	3:30036453-134858252																				17.72						0.730304227093642	0.636006512326363	0.862222958307612	0.85336181383742	0.386394557252369	607640	Spinocerebellar ataxia 7, 164500 (3)	AD	yes		1	9.5950e-01	9.2856e-01			full=NA
3_129172576_129172656_<STR15>,<STR16>_1	3	129172576	129172656		<STR15>,<STR16>	HG002	.	A	<STR15>,<STR16>	.	PASS	END=129172656;REF=20;RL=80;RU=CAGG;VARID=CNBP;REPID=CNBP	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:15/16:15-15/16-16:9/12:50/50:0/0:40.996214	full	CNBP	1																																				IMH	3:30036453-134858252;3:72502418-189537676;3:125769807-129999879			0.630	0.580	3:129172299-129172573;3:129172576-129172659;3:129172659-129172695	AluSx;(CAGG)n;(ACAG)n	3:129172299-129172573;3:129172576-129172659;3:129172659-129172695;3:129172695-129172733	AluSx;(CAGG)n;(ACAG)n;(AC)n												10.92						1.01216653226968	0.563475193327092	0.859240177546605	0.683528847927585	2.99129438863035	116955			yes			9.5994e-01	9.2057e-01			NA
3_129172576_129172656_<STR15>,<STR16>_1	3	129172576	129172656		<STR15>,<STR16>	HG002	.	A	<STR15>,<STR16>	.	PASS	END=129172656;REF=20;RL=80;RU=CAGG;VARID=CNBP;REPID=CNBP	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:15/16:15-15/16-16:9/12:50/50:0/0:40.996214	split	CNBP		NM_001127192	129167826	129183896	80	0	0	no	5	intron1-intron1	5'UTR	805	3'	129172576	129172656																						IMH	3:30036453-134858252;3:72502418-189537676;3:125769807-129999879																				10.92						1.01216653226968	0.563475193327092	0.859240177546605	0.683528847927585	2.99129438863035	116955	Myotonic dystrophy 2, 602668 (3)	AD	yes		1	9.5994e-01	9.2057e-01			full=NA
3_129172656_129172696_<STR7>,<STR9>_1	3	129172656	129172696		<STR7>,<STR9>	HG002	.	G	<STR7>,<STR9>	.	PASS	END=129172696;REF=10;RL=40;RU=CAGA;VARID=CNBP_CAGA;REPID=CNBP_CAGA	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:7/9:7-7/9-9:18/16:19/22:0/0:40.996214	full	CNBP	1																																				IMH	3:30036453-134858252;3:72502418-189537676;3:125769807-129999879			0.580	0.525	3:129172299-129172573;3:129172576-129172659;3:129172659-129172695;3:129172695-129172733	AluSx;(CAGG)n;(ACAG)n;(AC)n	3:129172576-129172659;3:129172659-129172695;3:129172695-129172733	(CAGG)n;(ACAG)n;(AC)n												10.92						1.01216653226968	0.563475193327092	0.859240177546605	0.683528847927585	2.99129438863035	116955			yes			9.5994e-01	9.2057e-01			NA
3_129172656_129172696_<STR7>,<STR9>_1	3	129172656	129172696		<STR7>,<STR9>	HG002	.	G	<STR7>,<STR9>	.	PASS	END=129172696;REF=10;RL=40;RU=CAGA;VARID=CNBP_CAGA;REPID=CNBP_CAGA	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:7/9:7-7/9-9:18/16:19/22:0/0:40.996214	split	CNBP		NM_001127192	129167826	129183896	40	0	0	no	5	intron1-intron1	5'UTR	885	3'	129172656	129172696																						IMH	3:30036453-134858252;3:72502418-189537676;3:125769807-129999879																				10.92						1.01216653226968	0.563475193327092	0.859240177546605	0.683528847927585	2.99129438863035	116955	Myotonic dystrophy 2, 602668 (3)	AD	yes		1	9.5994e-01	9.2057e-01			full=NA
3_129172696_129172732_<STR21>,<STR25>_1	3	129172696	129172732		<STR21>,<STR25>	HG002	.	A	<STR21>,<STR25>	.	PASS	END=129172732;REF=18;RL=36;RU=CA;VARID=CNBP_CA;REPID=CNBP_CA	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:21/25:21-21/25-25:19/14:28/32:0/0:40.996214	full	CNBP	1																																				IMH	3:30036453-134858252;3:72502418-189537676;3:125769807-129999879			0.525	0.465	3:129172576-129172659;3:129172659-129172695;3:129172695-129172733	(CAGG)n;(ACAG)n;(AC)n	3:129172576-129172659;3:129172659-129172695;3:129172695-129172733	(CAGG)n;(ACAG)n;(AC)n												10.92						1.01216653226968	0.563475193327092	0.859240177546605	0.683528847927585	2.99129438863035	116955			yes			9.5994e-01	9.2057e-01			NA
3_129172696_129172732_<STR21>,<STR25>_1	3	129172696	129172732		<STR21>,<STR25>	HG002	.	A	<STR21>,<STR25>	.	PASS	END=129172732;REF=18;RL=36;RU=CA;VARID=CNBP_CA;REPID=CNBP_CA	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:21/25:21-21/25-25:19/14:28/32:0/0:40.996214	split	CNBP		NM_001127192	129167826	129183896	36	0	0	no	5	intron1-intron1	5'UTR	925	3'	129172696	129172732																						IMH	3:30036453-134858252;3:72502418-189537676;3:125769807-129999879																				10.92						1.01216653226968	0.563475193327092	0.859240177546605	0.683528847927585	2.99129438863035	116955	Myotonic dystrophy 2, 602668 (3)	AD	yes		1	9.5994e-01	9.2057e-01			full=NA
4_3074876_3074933_<STR17>,<STR24>_1	4	3074876	3074933		<STR17>,<STR24>	HG002	.	C	<STR17>,<STR24>	.	PASS	END=3074933;REF=19;RL=57;RU=CAG;VARID=HTT;REPID=HTT	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:17/24:17-17/24-24:19/5:33/42:0/0:39.771228	full	HTT	1															HTT-AS															gnomAD-SV_v2.1_DUP_4_10990	4:3070772-3076273					IMH	4:1330316-92330038;4:2821272-17704603			0.710	0.710	4:3074876-3074940;4:3074940-3075052	(CAG)n;(CGC)n	4:3074876-3074940;4:3074940-3075052	(CAG)n;(CGC)n												7.59						-0.672019089975884	1.20702378077388	0.455761090475751	-0.292338464564844	2.75557960790302	182138;613004			yes	yes						NA
4_3074876_3074933_<STR17>,<STR24>_1	4	3074876	3074933		<STR17>,<STR24>	HG002	.	C	<STR17>,<STR24>	.	PASS	END=3074933;REF=19;RL=57;RU=CAG;VARID=HTT;REPID=HTT	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/SPANNING:17/24:17-17/24-24:19/5:33/42:0/0:39.771228	split	HTT		NM_002111	3074680	3243960	57	57	0	no	67	exon1-exon1	CDS	155	5'	3074876	3074933																gnomAD-SV_v2.1_DUP_4_10990	4:3070772-3076273					IMH	4:1330316-92330038;4:2821272-17704603																				7.59						-0.672019089975884	1.20702378077388	0.455761090475751	-0.292338464564844	2.75557960790302	182138;613004	Huntington disease, 143100 (3);Lopes-Maciel-Rodan syndrome, 617435 (3);(Anxiety-related personality traits), 607834 (3);(Obsessive-compulsive disorder), 164230 (3)	AD;AR;	yes	yes	0	1.0000e+00	1.0000e+00			full=NA
4_39348424_39348479_<STR12>,<STR59>_1	4	39348424	39348479		<STR12>,<STR59>	HG002	.	A	<STR12>,<STR59>	.	PASS	END=39348479;REF=11;RL=55;RU=AARRG;VARID=RFC1;REPID=RFC1	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/INREPEAT:12/59:12-12/45-77:10/0:40/46:0/16:35.279611	full	RFC1	1																																				IMH	4:1330316-92330038;4:4772331-76608755;4:21291889-139485605;4:21757281-83521389;4:32217846-78249129			0.415	0.350	4:39348145-39348424;4:39348424-39348483;4:39348483-39349246	AluSx3;(AAAAG)n;MLT1A-int	4:39348145-39348424;4:39348424-39348483;4:39348483-39349246	AluSx3;(AAAAG)n;MLT1A-int												17.7						-2.62354415217069	-1.30248731991161	-1.7773813207572	-0.847379340057227	0.23824197016376	102579			yes			9.7305e-01	1.7549e-01			NA
4_39348424_39348479_<STR12>,<STR59>_1	4	39348424	39348479		<STR12>,<STR59>	HG002	.	A	<STR12>,<STR59>	.	PASS	END=39348479;REF=11;RL=55;RU=AARRG;VARID=RFC1;REPID=RFC1	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/2:SPANNING/INREPEAT:12/59:12-12/45-77:10/0:40/46:0/16:35.279611	split	RFC1		NM_001204747	39287455	39366362	55	0	0	no	25	intron2-intron2	CDS	2868	5'	39348424	39348479																						IMH	4:1330316-92330038;4:4772331-76608755;4:21291889-139485605;4:21757281-83521389;4:32217846-78249129																				17.7						-2.62354415217069	-1.30248731991161	-1.7773813207572	-0.847379340057227	0.23824197016376	102579	Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome, 614575 (3)	AR	yes		1	9.7305e-01	1.7549e-01			full=NA
6_16327633_16327723_<STR31>_1	6	16327633	16327723		<STR31>	HG002	.	G	<STR31>	.	PASS	END=16327723;REF=30;RL=90;RU=TGC;VARID=ATXN1;REPID=ATXN1	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:30/31:30-30/31-31:7/10:44/44:0/0:43.854516	full	ATXN1	1																																								0.655	0.650	6:16327633-16327724	(TGC)n	6:16327633-16327724	(TGC)n												5.05									-0.22262436652196	2.48613742062414	601556			yes			9.7498e-01	3.9866e-01			NA
6_16327633_16327723_<STR31>_1	6	16327633	16327723		<STR31>	HG002	.	G	<STR31>	.	PASS	END=16327723;REF=30;RL=90;RU=TGC;VARID=ATXN1;REPID=ATXN1	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:30/31:30-30/31-31:7/10:44/44:0/0:43.854516	split	ATXN1		NM_001128164	16299111	16761460	90	90	3	no	8	exon7-exon7	CDS	747	3'	16327633	16327723																																											5.05									-0.22262436652196	2.48613742062414	601556	Spinocerebellar ataxia 1, 164400 (3)	AD	yes		1	9.7498e-01	3.9866e-01			full=NA
6_170561906_170562017_<STR36>_1	6	170561906	170562017		<STR36>	HG002	.	G	<STR36>	.	PASS	END=170562017;REF=37;RL=111;RU=GCA;VARID=TBP;REPID=TBP	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:37/36:37-37/36-36:3/7:46/45:0/0:31.359654	full	TBP	1																																								0.530	0.610	6:170561906-170562017	(GCA)n	6:170561906-170562017	(GCA)n												6.48						0.00919528286791156	-2.27838813328863	-1.7440270009601	-0.408801818931715	2.20111482259452	600075			yes	yes		1.5031e-02	4.9081e-01			NA
6_170561906_170562017_<STR36>_1	6	170561906	170562017		<STR36>	HG002	.	G	<STR36>	.	PASS	END=170562017;REF=37;RL=111;RU=GCA;VARID=TBP;REPID=TBP	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:37/36:37-37/36-36:3/7:46/45:0/0:31.359654	split	TBP		NM_001172085	170554332	170572870	111	111	11	no	7	exon2-exon2	CDS	116	3'	170561906	170562017																																											6.48						0.00919528286791156	-2.27838813328863	-1.7440270009601	-0.408801818931715	2.20111482259452	600075	Spinocerebellar ataxia 17, 607136 (3);(Parkinson disease, susceptibility to), 168600 (3)	AD;Multifactorial, AD	yes	yes	3	1.5031e-02	4.9081e-01			full=NA
9_27573528_27573546_<STR2>_1	9	27573528	27573546		<STR2>	HG002	.	C	<STR2>	.	PASS	END=27573546;REF=3;RL=18;RU=GGCCCC;VARID=C9ORF72;REPID=C9ORF72	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/1:SPANNING/SPANNING:2/2:2-2/2-2:49/49:9/9:0/0:51.531098	full	C9orf72	1															C9orf72 (morbid)																									0.725	0.700	9:27573484-27573546	(GCCCCG)n	9:27573484-27573546	(GCCCCG)n												11.73						-1.43365950702464	-0.297509028473295	-0.76830156421199	-1.69077452406282	0.0160477419573943	614260			yes			1.0647e-06	7.1513e-04			NA
9_27573528_27573546_<STR2>_1	9	27573528	27573546		<STR2>	HG002	.	C	<STR2>	.	PASS	END=27573546;REF=3;RL=18;RU=GGCCCC;VARID=C9ORF72;REPID=C9ORF72	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/1:SPANNING/SPANNING:2/2:2-2/2-2:49/49:9/9:0/0:51.531098	split	C9orf72		NM_001256054	27546545	27573866	18	0	0	no	11	intron1-intron1	5'UTR	162	5'	27573528	27573546																																											11.73						-1.43365950702464	-0.297509028473295	-0.76830156421199	-1.69077452406282	0.0160477419573943	614260	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, 105550 (3)	AD	yes		5	1.0647e-06	7.1513e-04			full=NA
9_69037261_69037286_<STR28>_1	9	69037261	69037286		<STR28>	HG002	.	T	<STR28>	.	PASS	END=69037286;REF=25;RL=25;RU=A;VARID=FXN_A;REPID=FXN_A	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:25/28:25-25/28-28:18/14:11/11:0/0:39.117902	full	FXN	1															FAM122A;FXN (morbid);PIP5K1B;PRKACG;TJP2 (morbid)																					IMH	9:65437054-134286391			0.450	0.460	9:69037141-69037494	AluSx	9:69037141-69037494	AluSx												66.77						-0.903609614373761	-1.20985855447785	-1.16534074828701	-0.104401815070801	0.813331274759873	606829			yes			3.4491e-01	8.1775e-01			NA
9_69037261_69037286_<STR28>_1	9	69037261	69037286		<STR28>	HG002	.	T	<STR28>	.	PASS	END=69037286;REF=25;RL=25;RU=A;VARID=FXN_A;REPID=FXN_A	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	0/1:SPANNING/SPANNING:25/28:25-25/28-28:18/14:11/11:0/0:39.117902	split	FXN		NM_000144	69035751	69079076	25	0	0	no	5	intron1-intron1	CDS	1314	5'	69037261	69037286																						IMH	9:65437054-134286391																		30	0	66.77						-0.903609614373761	-1.20985855447785	-1.16534074828701	-0.104401815070801	0.813331274759873	606829	Friedreich ataxia with retained reflexes, 229300 (3);Friedreich ataxia, 229300 (3)	AR	yes		3	3.4491e-01	8.1775e-01			full=NA
9_69037286_69037304_<STR9>_1	9	69037286	69037304		<STR9>	HG002	.	A	<STR9>	.	PASS	END=69037304;REF=6;RL=18;RU=GAA;VARID=FXN;REPID=FXN	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/1:SPANNING/SPANNING:9/9:9-9/9-9:28/28:18/18:0/0:39.117902	full	FXN	1															FAM122A;FXN (morbid);PIP5K1B;PRKACG;TJP2 (morbid)																					IMH	9:65437054-134286391			0.460	0.475	9:69037141-69037494	AluSx	9:69037141-69037494	AluSx												66.77						-0.903609614373761	-1.20985855447785	-1.16534074828701	-0.104401815070801	0.813331274759873	606829			yes			3.4491e-01	8.1775e-01			NA
9_69037286_69037304_<STR9>_1	9	69037286	69037304		<STR9>	HG002	.	A	<STR9>	.	PASS	END=69037304;REF=6;RL=18;RU=GAA;VARID=FXN;REPID=FXN	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1/1:SPANNING/SPANNING:9/9:9-9/9-9:28/28:18/18:0/0:39.117902	split	FXN		NM_000144	69035751	69079076	18	0	0	no	5	intron1-intron1	CDS	1339	5'	69037286	69037304																						IMH	9:65437054-134286391																		30	0	66.77						-0.903609614373761	-1.20985855447785	-1.16534074828701	-0.104401815070801	0.813331274759873	606829	Friedreich ataxia with retained reflexes, 229300 (3);Friedreich ataxia, 229300 (3)	AR	yes		3	3.4491e-01	8.1775e-01			full=NA
X_67545316_67545385_<STR27>_1	X	67545316	67545385		<STR27>	HG002	.	T	<STR27>	.	PASS	END=67545385;REF=23;RL=69;RU=GCA;VARID=AR;REPID=AR	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1:SPANNING:27:27-27:1:21:0:16.904813	full	AR	1																												6	Absent_axillary_hair;Absent_pubic_hair;Androgen_resistance_syndrome;Aplasia_of_the_uterus;Bulbo-spinal_atrophy_X-linked;Female_external_genitalia_in_individual_with_46,XY_karyotype							IMH	X:65387005-68605087			0.665	0.645	X:67545316-67545419	(GCA)n	X:67545316-67545419	(GCA)n										3		0.35									-0.0209058563241717	1.57842633474417	313700			yes	yes		9.8837e-01	9.9491e-01			NA
X_67545316_67545385_<STR27>_1	X	67545316	67545385		<STR27>	HG002	.	T	<STR27>	.	PASS	END=67545385;REF=23;RL=69;RU=GCA;VARID=AR;REPID=AR	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1:SPANNING:27:27-27:1:21:0:16.904813	split	AR		NM_000044	67544020	67730619	69	69	2	no	8	exon1-exon1	CDS	1377	5'	67545316	67545385														6	Absent_axillary_hair;Absent_pubic_hair;Androgen_resistance_syndrome;Aplasia_of_the_uterus;Bulbo-spinal_atrophy_X-linked;Female_external_genitalia_in_individual_with_46,XY_karyotype							IMH	X:65387005-68605087																		3	0	0.35	both RD and IF	hemizygous	dominant negative;loss of function	ANDROGEN INSENSITIVITY SYNDROME;SPINAL AND BULBAR MUSCULAR ATROPHY					-0.0209058563241717	1.57842633474417	313700	Androgen insensitivity, 300068 (3);Androgen insensitivity, partial, with or without breast cancer, 312300 (3);Hypospadias 1, XL, 300633 (3);Spinal and bulbar muscular atrophy of Kennedy, 313200 (3);(Prostate cancer, susceptibility to), 176807 (3)	Somatic mutation, AD;XLR	yes	yes	1	9.8837e-01	9.9491e-01			full=NA
X_147912050_147912110_<STR31>_1	X	147912050	147912110		<STR31>	HG002	.	G	<STR31>	.	PASS	END=147912110;REF=20;RL=60;RU=CGG;VARID=FMR1;REPID=FMR1	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1:SPANNING:31:31-31:10:17:0:18.129800	full	FMR1	1															FMR1-AS1																									0.875	0.820	X:147911978-147912111	(GGC)n	X:147911978-147912111	(GGC)n										3		2.45									0.925952363469401	3.04370283043583	309550			yes			6.4718e-01	1.2720e-01			NA
X_147912050_147912110_<STR31>_1	X	147912050	147912110		<STR31>	HG002	.	G	<STR31>	.	PASS	END=147912110;REF=20;RL=60;RU=CGG;VARID=FMR1;REPID=FMR1	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1:SPANNING:31:31-31:10:17:0:18.129800	split	FMR1		NM_001185081	147911918	147951121	60	0	0	no	15	exon1-exon1	5'UTR	120	5'	147912050	147912110																																									3	0	2.45	both RD and IF;confirmed	hemizygous;x-linked dominant	activating;loss of function;uncertain	FRAGILE X SYNDROME;FRAGILE X TREMOR/ATAXIA SYNDROME;PREMATURE OVARIAN FAILURE SYNDROME TYPE 1					0.925952363469401	3.04370283043583	309550	Fragile X syndrome, 300624 (3);Fragile X tremor/ataxia syndrome, 300623 (3);Premature ovarian failure 1, 311360 (3)	XL;XLD	yes		1	6.4718e-01	1.2720e-01			full=NA
X_148500631_148500691_<STR19>_1	X	148500631	148500691		<STR19>	HG002	.	A	<STR19>	.	PASS	END=148500691;REF=20;RL=60;RU=GCC;VARID=AFF2;REPID=AFF2	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1:SPANNING:19:19-19:14:14:0:16.333153	full	AFF2	1																																								0.810	0.885	X:148500601-148500743	(GCC)n	X:148500601-148500743;X:148500743-148500788;X:148500788-148500815	(GCC)n;(GCCA)n;(GCC)n										3		2.76									-1.50577113578708	1.21840738767441	300806			yes			9.9577e-01	9.9876e-01			NA
X_148500631_148500691_<STR19>_1	X	148500631	148500691		<STR19>	HG002	.	A	<STR19>	.	PASS	END=148500691;REF=20;RL=60;RU=GCC;VARID=AFF2;REPID=AFF2	GT:SO:REPCN:REPCI:ADSP:ADFL:ADIR:LC	1:SPANNING:19:19-19:14:14:0:16.333153	split	AFF2		NM_001169122	148500616	149000663	60	0	0	no	20	exon1-exon1	5'UTR	453	5'	148500631	148500691																																									3	0	2.76	confirmed	hemizygous	loss of function	FRAGILE X-E MENTAL RETARDATION SYNDROME	21739600;8334699				-1.50577113578708	1.21840738767441	300806	Mental retardation, XL, FRAXE type, 309548 (3)	XLR	yes		1	9.9577e-01	9.9876e-01			full=NA
